Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 0 | 258 | 41,297 | 5,442 | 14,189 |
| Gross Profit | N/A | 258 | 41,297 | 5,442 | 14,189 |
| Operating Expenses | 9,926 | 7,796 | 9,892 | 13,358 | 16,633 |
| Operating Income | -9,926 | -7,538 | 31,405 | -7,916 | -2,444 |
| Other Income | 374 | 335 | 376 | 534 | 744 |
| Pre-tax Income | -9,552 | -7,203 | 31,781 | -7,382 | -1,700 |
| Net Income Continuous | -9,552 | -7,203 | 31,520 | -7,382 | -1,700 |
| Net Income | $-9,552 | $-7,203 | $31,520 | $-7,382 | $-1,700 |
| EPS Basic Total Ops | -0.16 | -0.13 | 0.56 | -0.13 | -0.03 |
| EPS Basic Continuous Ops | -0.16 | -0.13 | 0.56 | -0.13 | -0.03 |
| EPS Diluted Total Ops | -0.16 | -0.13 | 0.56 | -0.13 | -0.03 |
| EPS Diluted Continuous Ops | -0.16 | -0.13 | 0.56 | -0.13 | -0.03 |
| EPS Diluted Before Non-Recurring Items | -0.16 | -0.13 | 0.53 | -0.13 | -0.03 |
| EBITDA(a) | $-9,926 | $-7,538 | $31,405 | $-7,916 | $-2,444 |